The global Pollen Allergy market is anticipated to be worth US$ 5850.8 million in 2023, growing at a 4.2% CAGR. The market is estimated to reach US$ 8828.6 million by 2033 as a result of technological developments in healthcare.
The growing number of people suffering from pollen-based allergies, such as hay fever, is propelling market growth. Furthermore, the global Pollen Allergy market is expanding as the number of sufferers, particularly children, grows. During the forecast period, rapid urbanisation in emerging economies will be a major factor driving the growth of the Pollen Allergy market.
Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16236
Increased greenhouse gas emissions may cause pollen-induced reparative sickness, reducing the Pollen Allergy industry’s growth.
Corticosteroids dominated the Pollen Allergy market in terms of revenue share, and their use as a first-line treatment is projected to contribute to market expansion.
Because of the increasing frequency of allergies and awareness of therapy, North America has dominated the worldwide Pollen Allergy market. Europe’s Pollen Allergy market is predicted to be the world’s second largest. Another major aspect that could enhance market expansion in this region is increased disease awareness among individuals.
Key Takeaways from the Market Study
- In 2023, the Pollen Allergy market was worth $5850.8 million.
- Between 2023 and 2033, the Pollen Allergy industry is predicted to grow at a 4.2% CAGR.
- By 2033, the Pollen Allergy market is anticipated to be valued US$ 8828.6 million.
- In 2023, corticosteroids controlled the Pollen Allergy market, contributing for 35.5% of total revenue.
- China is anticipated to create a CAGR of 3.8% in pollen allergies by 2033.
“Technological advancement in healthcare and increase in the prevalence of allergic rhinitis and rise in the number of patients especially children suffering from pollen allergies expected to radically transform the Pollen Allergy market in the coming years,” comments an analyst at FMI.
For critical insights on this market, ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16236
Competitive Landscape
Some of the leading manufacturers and players assessed in the global Pollen Allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc. and others
Manufacturers and players functional in the global Pollen Allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.
- In the summer of 2022 – Stallergenes Greer, a global healthcare firm specialised in allergen immunotherapy (AIT), revealed today that its EfficAPSI real-world research yielded promising results. The real-world study, which was presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), confirmed a significant benefit of sublingual liquid allergen immunotherapy (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
- With the Multi-Test PC (pain control), Lincoln Diagnostics provides a painless option for skin allergy testing. This test still has great sensitivity, specificity, and minimal variability in outcomes while being essentially painless.
More insights available
The North American region has a significant Pollen Allergies market share due to the high prevalence of allergies, favorable reimbursement policies, and the presence of key market players. The European region also has a substantial market share due to the growing prevalence of allergies, high healthcare spending, and increasing awareness about the available treatment options.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16236
Key Segments Covered in the Pollen Allergy Industry Survey
Pollen Allergy Market by Product Type:
- Instruments
- Consumables
- Services
Pollen Allergy Market by Allergen Type:
- Food
- Inhaled
- Drug
- Other
Pollen Allergy Market by Therapeutics Drug class:
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Immunomodulators
- Auto injectable Epinephrine
- Immunotherapy
Pollen Allergy Market by End-User:
- Diagnostic Laboratories
- Hospitals
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
